As research continues to expand understanding of copper peptide mechanisms, clinical applications are likely to evolve and improve
TB-500, a synthetic analog of thymosin beta-4, has demonstrated benefits in modulating actin dynamics, improving cell migration, and promoting angiogenesis
10.1021/acschemneuro.4c00620 65 LiangD.FengY.ZandkarimiF.WangH.ZhangZ.KimJ.et al (2023)
GHK-Cu is not FDA-approved for anti-aging or cosmetic purposes
Until that work is published, the appropriate scientific posture is measured: cagrilintide has a strong mechanistic and short-term case for affecting gastric emptying and postprandial metabolism, an encouraging but combination-confounded clinical dataset, and an unresolved question about durability
However, the same theoretical concerns regarding chemotherapy agents apply [2][5]